The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
200 jobs Number of planned job losses
200 jobs Number of planned job creations
Announcement Date
7 June 2021
Employment effect (start)
7 June 2021
Foreseen end date
31 July 2022
Description
The American pharmaceutical company, Pfizer, in October 2021 announced the creation of additional 200 new jobs in Thessaloniki Greece, by the end of 2022. Pfizer, from March 2021 started the operation of two new HUBs in Thessaloniki, Greece. The two new investments are the creation of the Company's first Digital Innovation Center (CDI) and the establishment of one Global Center for Business Operations and Services.
The investment in Thessaloniki is one of Pfizer's six Global Centers for Business Operations and Services.
Eurofound (2021), Pfizer, Business expansion in Greece, factsheet number 106902, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/106902.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
